Literature DB >> 9578421

MAGE-1 expression threshold for the lysis of melanoma cell lines by a specific cytotoxic T lymphocyte.

B Lethé1, P van der Bruggen, F Brasseur, T Boon.   

Abstract

Human gene MAGE-1 codes for an antigen that is recognized on a melanoma by an autologous cytotoxic T lymphocyte (CTL). Because MAGE-1 is expressed on a significant proportion of tumours of various histological types and not on normal tissues, the encoded antigen may serve as a target for cancer immunotherapy. Evaluation of the expression of the gene by reverse transcription polymerase chain reaction (RT-PCR) in various tumour samples and tumour cell lines has suggested great variability in the level of expression. It was therefore important to evaluate the minimal level of expression required for lysis by CTL. We tested a number of melanoma cell lines by a quantitative RT-PCR assay to correlate their level of MAGE-1 expression and recognition by the relevant CTL clone. We found that only cell lines expressing more than 10% of the MAGE-1 messenger RNA (mRNA) level of reference cell line MZ2-MEL.3.0 (i.e. more than three mRNA molecules per cell) were lysed by the CTL or induced significant tumour necrosis factor release.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9578421

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  10 in total

1.  Marek's disease is a natural model for lymphomas overexpressing Hodgkin's disease antigen (CD30).

Authors:  S C Burgess; J R Young; B J G Baaten; L Hunt; L N J Ross; M S Parcells; P M Kumar; C A Tregaskes; L F Lee; T F Davison
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-08       Impact factor: 11.205

Review 2.  Cancer gene and immunotherapy: recent developments.

Authors:  P Jantscheff; R Herrmann; C Rochlitz
Journal:  Med Oncol       Date:  1999-07       Impact factor: 3.064

3.  DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter.

Authors:  C De Smet; C Lurquin; B Lethé; V Martelange; T Boon
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

4.  Quantification of SSX mRNA expression in human bone and soft tissue tumors using nucleic acid sequence-based amplification.

Authors:  Norifumi Naka; Susumu Joyama; Yoshitane Tsukamoto; Kiyoko Yoshioka; Nobuyuki Hashimoto; Takeshi Ujiiye; Tsukasa Hayashi; Masako Kawase; Masayuki Mano; Shingo Ishiguro; Akira Myoui; Takafumi Ueda; Hideki Yoshikawa; Nobuhito Araki; Kazuyuki Itoh
Journal:  J Mol Diagn       Date:  2005-05       Impact factor: 5.568

5.  Quantitative expression and immunogenicity of MAGE-3 and -6 in upper aerodigestive tract cancer.

Authors:  Pedro A Andrade Filho; Andrés López-Albaitero; Liqiang Xi; William Gooding; Tony Godfrey; Robert L Ferris
Journal:  Int J Cancer       Date:  2009-10-15       Impact factor: 7.396

6.  Cytotoxic T lymphocyte responses against melanocytes and melanoma.

Authors:  Gwendolen Y Chang; Holbrook E Kohrt; Tor B Stuge; Erich J Schwartz; Jeffrey S Weber; Peter P Lee
Journal:  J Transl Med       Date:  2011-07-27       Impact factor: 5.531

7.  A new antigen recognized by cytolytic T lymphocytes on a human kidney tumor results from reverse strand transcription.

Authors:  B J Van Den Eynde; B Gaugler; M Probst-Kepper; L Michaux; O Devuyst; F Lorge; P Weynants; T Boon
Journal:  J Exp Med       Date:  1999-12-20       Impact factor: 14.307

8.  Efficient identification of novel HLA-A(*)0201-presented cytotoxic T lymphocyte epitopes in the widely expressed tumor antigen PRAME by proteasome-mediated digestion analysis.

Authors:  J H Kessler; N J Beekman; S A Bres-Vloemans; P Verdijk; P A van Veelen; A M Kloosterman-Joosten; D C Vissers; G J ten Bosch; M G Kester; A Sijts; J Wouter Drijfhout; F Ossendorp; R Offringa; C J Melief
Journal:  J Exp Med       Date:  2001-01-01       Impact factor: 14.307

9.  A human minor histocompatibility antigen specific for B cell acute lymphoblastic leukemia.

Authors:  H Dolstra; H Fredrix; F Maas; P G Coulie; F Brasseur; E Mensink; G J Adema; T M de Witte; C G Figdor; E van de Wiel-van Kemenade
Journal:  J Exp Med       Date:  1999-01-18       Impact factor: 14.307

10.  Translation of a retained intron in tyrosinase-related protein (TRP) 2 mRNA generates a new cytotoxic T lymphocyte (CTL)-defined and shared human melanoma antigen not expressed in normal cells of the melanocytic lineage.

Authors:  R Lupetti; P Pisarra; A Verrecchia; C Farina; G Nicolini; A Anichini; C Bordignon; M Sensi; G Parmiani; C Traversari
Journal:  J Exp Med       Date:  1998-09-21       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.